Botulinum Toxin Injections for Shoulder and Upper Limb Pain: A Narrative Review

References

• Andringa A , vande Port I , van WegenE , KetJ , MeskersC , KwakkelG. Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains: a systematic review and meta-analysis. Arch. Phys. Med. Rehabil.100(9), 1703–1725 (2019).
   PubMed Web of Science ®Google Scholar
• Kaymak B , KaraM , GurcayE , OzcakarL. Sonographic guide for botulinum toxin injections of the neck muscles in cervical dystonia. Phys. Med. Rehabil. Clin. N. Am.29(1), 105–123 (2018).
   PubMed Web of Science ®Google Scholar
• Patil S , WillettO , ThompkinsTet.al Botulinum toxin: pharmacology and therapeutic roles in pain states. Curr. Pain Headache Rep.20(3), 15 (2016).
   PubMed Web of Science ®Google Scholar
• Lin YC , WuWT , HsuYC , HanDS , ChangKV. Comparative effectiveness of botulinum toxin versus non-surgical treatments for treating lateral epicondylitis: a systematic review and meta-analysis. Clin. Rehabil.32(2), 131–145 (2018).
   PubMed Web of Science ®Google Scholar
• Meng J , WangJ , LawrenceG , DollyJO. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J. Cell Sci.120(Pt 16), 2864–2874 (2007).
   PubMed Web of Science ®Google Scholar
• Lucioni A , BalesGT , LotanTL , McGeheeDS , CookSP , RappDE. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int.101(3), 366–370 (2008).
   PubMed Web of Science ®Google Scholar
• Matak I , RiedererP , LackovicZ. Botulinum toxin’s axonal transport from periphery to the spinal cord. Neurochem. Int.61(2), 236–239 (2012).
   PubMed Web of Science ®Google Scholar
• Hsu PC , WuWT , HanDS , ChangKV. Comparative effectiveness of botulinum toxin injection for chronic shoulder pain: a meta-analysis of randomized controlled trials. Toxins (Basel)12(4), (2020).
   Web of Science ®Google Scholar
• Nigam PK , NigamA. Botulinum toxin. Indian J. Dermatol.55(1), 8–14 (2010).
   PubMedGoogle Scholar
• Samizadeh S , DeBoulle K. Botulinum neurotoxin formulations: overcoming the confusion. Clin. Cosmet. Investig. Dermatol.11, 273–287 (2018).
   PubMed Web of Science ®Google Scholar
• Kong KH , NeoJJ , ChuaKS. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Clin. Rehabil.21(1), 28–35 (2007).
   PubMed Web of Science ®Google Scholar
• Yelnik AP , ColleFM , BonanIV , VicautE. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J. Neurol. Neurosurg. Psychiatry78(8), 845–848 (2007).
   PubMed Web of Science ®Google Scholar
• Lim JY , KohJH , PaikNJ. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Stroke39(1), 126–131 (2008).
   PubMed Web of Science ®Google Scholar
• Pedreira G , CardosoE , MeloA. Botulinum toxin type A for refractory post-stroke shoulder pain. Arq. Neuropsiquiatr.66(2A), 213–215 (2008).
   PubMed Web of Science ®Google Scholar
• Castiglione A , BagnatoS , BoccagniC , RomanoMC , GalardiG. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain. Arch. Phys. Med. Rehabil.92(7), 1034–1037 (2011).
   PubMed Web of Science ®Google Scholar
• Marciniak CM , HarveyRL , GagnonCMet.al Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial. Am. J. Phys. Med. Rehabil.91(12), 1007–1019 (2012).
   PubMed Web of Science ®Google Scholar
• Choi JG , ShinJH , KimBR. Botulinum toxin A injection into the subscapularis muscle to treat intractable hemiplegic shoulder pain. Ann. Rehabil. Med.40(4), 592–599 (2016).
   PubMedGoogle Scholar
• Holmes RJ , ConnellLA. A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK. Disabil. Rehabil.41(6), 720–726 (2019).
   PubMed Web of Science ®Google Scholar
• Wu T , SongHX , LiYZ , YeY , LiJH , HuXY. Clinical effectiveness of ultrasound guided subacromial-subdeltoid bursa injection of botulinum toxin type A in hemiplegic shoulder pain: a retrospective cohort study. Medicine (Baltimore)98(45), e17933 (2019).
   PubMed Web of Science ®Google Scholar
• Singh JA , MahowaldML , NoorbaloochiS. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial. Transl. Res.153(5), 205–216 (2009).
   PubMed Web of Science ®Google Scholar
• Lee JH , LeeSH , SongSH. Clinical effectiveness of botulinum toxin type B in the treatment of subacromial bursitis or shoulder impingement syndrome. Clin. J. Pain27(6), 523–528 (2011).
   PubMed Web of Science ®Google Scholar
• Joo YJ , YoonSJ , KimCWet.al A comparison of the short-term effects of a botulinum toxin type a and triamcinolone acetate injection on adhesive capsulitis of the shoulder. Ann. Rehabil. Med.37(2), 208–214 (2013).
   PubMedGoogle Scholar
• Cinone N , LetiziaS , SantoroLet.al Intra-articular injection of botulinum toxin type A for shoulder pain in glenohumeral osteoarthritis: a case series summary and review of the literature. J. Pain Res.11, 1239–1245 (2018).
   PubMed Web of Science ®Google Scholar
• Benecke R , HeinzeA , ReichelG , HefterH , GobelH. Dysport myofascial pain study G. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?Pain Med.12(11), 1607–1614 (2011).
   PubMed Web of Science ®Google Scholar
• Nicol AL , WuII , FerranteFM. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design. Anesth. Analg.118(6), 1326–1335 (2014).
   PubMed Web of Science ®Google Scholar
• Kim DY , KimJM. Safety and efficacy of prabotulinumtoxin A (Nabota((R))) injection for cervical and shoulder girdle myofascial pain syndrome: a pilot study. Toxins (Basel)10(9), (2018).
   Web of Science ®Google Scholar
• Safarpour D , SalardiniA , RichardsonD , JabbariB. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. Pain Med.11(9), 1411–1414 (2010).
   PubMed Web of Science ®Google Scholar
• Bellon G , VenturinA , MasieroS , DelFelice A. Intra-articular botulinum toxin injection in complex regional pain syndrome: case report and review of the literature. Toxicon159, 41–44 (2019).
   PubMed Web of Science ®Google Scholar
• De Groef A , DevoogdtN , Van KampenMet.al Effectiveness of botulinum toxin a for persistent upper limb pain after breast cancer treatment: a double-blinded randomized controlled trial. Arch. Phys. Med. Rehabil.99(7), 1342–1351 (2018).
   PubMed Web of Science ®Google Scholar
• Park J , ParkHJ. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel)9(9), (2017).
   Web of Science ®Google Scholar
• Naumann M , BooLM , AckermanAH , GallagherCJ. Immunogenicity of botulinum toxins. J. Neural. Transm. (Vienna)120(2), 275–290 (2013).
   PubMed Web of Science ®Google Scholar
• Gronseth G , FrenchJ. Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology71(20), 1639–1643 (2008).
   PubMed Web of Science ®Google Scholar